Skip to main content
Top
Published in: JA Clinical Reports 1/2022

Open Access 01-12-2022 | Malignant Hyperthermia | Case report

Use of remimazolam in living donor liver transplantation: a case report

Authors: Tsuguhiro Matsumoto, Kotaro Sakurai, Kazuyo Takahashi, Shuji Kawamoto

Published in: JA Clinical Reports | Issue 1/2022

Login to get access

Abstract

Background

Remimazolam is an intravenous ultra-short-acting benzodiazepine with the benefit of hemodynamic stability, including blood pressure and pulse rate. We report a case in which remimazolam was used in living donor liver transplantation with stable hemodynamics.

Case presentation

A 19-year-old woman underwent living donor liver transplantation due to end-stage liver disease, which is associated with a hyperdynamic state and hemodynamic instability. The patient’s sister had a history of malignant hyperthermia, so we chose total intravenous anesthesia with remimazolam. Intraoperative bleeding of seven liters occurred, but she had mild intraoperative blood pressure changes, and continuous catecholamine administration was not necessary. The patient had no memories or discomfort during the surgery.

Conclusions

We maintained stable hemodynamics using remimazolam for anesthetic management of a patient undergoing a liver transplantation, which is characterized by a hyperdynamic state and circulatory instability.
Literature
7.
Metadata
Title
Use of remimazolam in living donor liver transplantation: a case report
Authors
Tsuguhiro Matsumoto
Kotaro Sakurai
Kazuyo Takahashi
Shuji Kawamoto
Publication date
01-12-2022
Publisher
Springer Berlin Heidelberg
Published in
JA Clinical Reports / Issue 1/2022
Electronic ISSN: 2363-9024
DOI
https://doi.org/10.1186/s40981-022-00556-x

Other articles of this Issue 1/2022

JA Clinical Reports 1/2022 Go to the issue